VOGELXO Drug Patent Profile
✉ Email this page to a colleague
When do Vogelxo patents expire, and when can generic versions of Vogelxo launch?
Vogelxo is a drug marketed by Upsher Smith Labs and is included in one NDA. There are three patents protecting this drug.
This drug has seven patent family members in seven countries.
The generic ingredient in VOGELXO is testosterone. There are sixty-nine drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the testosterone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vogelxo
A generic version of VOGELXO was approved as testosterone by ACTAVIS LABS UT INC on January 27th, 2006.
Summary for VOGELXO
International Patents: | 7 |
US Patents: | 3 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Clinical Trials: | 1 |
Patent Applications: | 4,285 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VOGELXO |
What excipients (inactive ingredients) are in VOGELXO? | VOGELXO excipients list |
DailyMed Link: | VOGELXO at DailyMed |
Recent Clinical Trials for VOGELXO
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Upsher-Smith Laboratories | Phase 4 |
Pharmacology for VOGELXO
Drug Class | Androgen |
Mechanism of Action | Androgen Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for VOGELXO
US Patents and Regulatory Information for VOGELXO
VOGELXO is protected by three US patents.
Patents protecting VOGELXO
Testosterone gel compositions and related methods
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE
Testosterone gel compositions and related methods
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE
Testosterone gel compositions and related methods
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upsher Smith Labs | VOGELXO | testosterone | GEL, METERED;TRANSDERMAL | 204399-003 | Jun 4, 2014 | BX | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Upsher Smith Labs | VOGELXO | testosterone | GEL;TRANSDERMAL | 204399-002 | Jun 4, 2014 | AB2 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Upsher Smith Labs | VOGELXO | testosterone | GEL, METERED;TRANSDERMAL | 204399-003 | Jun 4, 2014 | BX | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Upsher Smith Labs | VOGELXO | testosterone | GEL, METERED;TRANSDERMAL | 204399-003 | Jun 4, 2014 | BX | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for VOGELXO
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
Warner Chilcott UK Ltd. | Intrinsa | testosterone | EMEA/H/C/000634 Intrinsa is indicated for the treatment of hypoactive sexual desire disorder (HSDD) in bilaterally oophorectomised and hysterectomised (surgically induced menopause) women receiving concomitant estrogen therapy. |
Withdrawn | no | no | no | 2006-07-28 | |
Warner Chilcott Deutschland GmbH | Livensa | testosterone | EMEA/H/C/000630 Livensa is indicated for the treatment of hypoactive sexual desire disorder (HSDD) in bilaterally oophorectomised and hysterectomised (surgically induced menopause) women receiving concomitant estrogen therapy. |
Withdrawn | no | no | no | 2006-07-28 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for VOGELXO
See the table below for patents covering VOGELXO around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 3079703 | COMPOSITIONS DE GEL DE TESTOSTÉRONE ET MÉTHODES ASSOCIÉES (TESTOSTERONE GEL COMPOSITIONS AND RELATED METHODS) | ⤷ Try a Trial |
China | 106376169 | 电路板及其制作方法 (Circuit board and manufacturing method thereof) | ⤷ Try a Trial |
Australia | 2014362275 | Testosterone gel compositions and related methods | ⤷ Try a Trial |
Hong Kong | 1223852 | 睪丸酮凝膠組合物及相關方法 (TESTOSTERONE GEL COMPOSITIONS AND RELATED METHODS) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |